Welcome to our dedicated page for Fairholme Allocation Fund news (Ticker: FAAFX), a resource for investors and traders seeking the latest updates and insights on Fairholme Allocation Fund stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Fairholme Allocation Fund's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Fairholme Allocation Fund's position in the market.
The Fairholme Fund (NASDAQ: FAIRX) will not distribute a dividend in 2022. However, the Fairholme Focused Income Fund (FOCIX) announced an Ordinary Income dividend of
Fairholme Fund (NASDAQ: FAIRX) announced it will not pay a dividend for 2021. In contrast, the Fairholme Focused Income Fund (NASDAQ: FOCIX) distributed an Ordinary Income dividend of $0.01906 per share on December 17, 2021, to shareholders of record as of December 16, 2021. The Fairholme Allocation Fund (NASDAQ: FAAFX) also distributed a dividend of $0.03277 per share on the same date. Both funds' Net Asset Values were reduced by the total distribution amounts.
